ALLMedicine™ Cardioversion Center

May 15th, 2022 - In the recent years, antithrombotic prophylaxis in patients with atrial fibrillation (AF) has changed significantly. The main aim of this study is to assess the temporal trends of antithrombotic therapy and identify factors predisposing oral antic...

May 6th, 2022 - Atrial fibrillation (AF) is the most common heart rhythm disorder. It is the result of uncoordinated action of the atrial myocardial cells, causing rapid and irregular contraction of the heart's atria. The AF prevalence in adults is currently esti...

Apr 30th, 2022 - To determine the potential prognostic value and clinical correlations of blood biomarkers in a cohort of patients with Tetralogy of Fallot (TOF). In the setting of multicenter prospective research studies TOF patients underwent blood sampling, car...

Apr 28th, 2022 - This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled clinical study designed to evaluate the efficacy and safety of FlecIH-103 (flecainide acetate inhalation solution) compared with placebo in patients with recent-onset, sy...

Apr 24th, 2022 - Pharmacological cardioversion (PCV) is commonly a primary option for termination of recent-onset atrial fibrillation (AF) in emergency departments (ED). This is a subanalysis of the CANT II study, evaluating the effectiveness and safety of antazol...

Nov 9th, 2018 - The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in atrial fibrillation (AF) management. This 2018 Focuse...

Sep 20th, 2015 - 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion).|2015|Zipes...

May 3rd, 2013 - Anticoagulants are a mainstay of cardiovascular therapy, and parenteral anticoagulants have widespread use in cardiology, especially in acute situations. Parenteral anticoagulants include unfractionated heparin, low-molecular-weight heparins, the ...

Feb 19th, 2011 - The stroke rate in atrial fibrillation is 4.5% per year, with death or permanent disability in over half. The risk of stroke varies from under 1% to over 20% per year, related to the risk factors of congestive heart failure, hypertension, age, dia...

May 6th, 2022 - Atrial fibrillation (AF) is the most common heart rhythm disorder. It is the result of uncoordinated action of the atrial myocardial cells, causing rapid and irregular contraction of the heart's atria. The AF prevalence in adults is currently esti...

Apr 28th, 2022 - This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled clinical study designed to evaluate the efficacy and safety of FlecIH-103 (flecainide acetate inhalation solution) compared with placebo in patients with recent-onset, sy...

Apr 14th, 2022 - This is a prospective, bicentric, observational cohort study which will be performed in University hospital center of Montpellier and Nîmes The study will include all consecutive patients, admitted for a percutaneous PFO closure after an ischemic ...

Apr 12th, 2022 - An assessment of the use of cold therapy to terminate atrial fibrillation.

Apr 7th, 2022 - Background Commercially available defibrillators generate direct current (DC) shock with various waveforms using distinct technologies. These waveforms are suggested to have different efficacy and safety. Although the superiority of biphasic over ...

Mar 15th, 2022 - The case for early rhythm control, achieved by ablation or cardioversion, in most patients with atrial fibrillation (AF) is mechanistically stronger with a new study suggesting the strategy can improve structural and functional heart damage from t...

Oct 15th, 2021 - Farrukh Awan, MD: Atrial fibrillation [AFib] is the most common issue with these patients [with chronic lymphocytic leukemia]. Another thing I learned the hard way is that when patients without a history of AFib got on a BTK inhibitor, with a rapi...

Oct 6th, 2021 - The 3 most common types of amyloidosis––TTR mutant, TTR wild-type, and amyloid light chain (AL)––have a significant amount of cardiac involvement, making cardiologists essential players in the diagnostic workup and treatment of these patients, exp...

Jul 1st, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. For the first half of 2021, the mRNA vaccines looked to be near perfect. The trials reported more than 90% efficacy for the Pfizer and Moderna vac...

Jun 22nd, 2021 - Obstructive sleep apnea (OSA) is common in patients with cardiovascular disease (CVD), yet it is often under-recognized and treated in cardiovascular practice, the American Heart Association (AHA) says in a new scientific statement. "Obstructive s...